153 related articles for article (PubMed ID: 36966422)
1. Impact of spatial metabolomics on immune-microenvironment in oral cancer prognosis: a clinical report.
Bag S; Oetjen J; Shaikh S; Chaudhary A; Arun P; Mukherjee G
Mol Cell Biochem; 2024 Jan; 479(1):41-49. PubMed ID: 36966422
[TBL] [Abstract][Full Text] [Related]
2. Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma.
Wirsing AM; Ervik IK; Seppola M; Uhlin-Hansen L; Steigen SE; Hadler-Olsen E
Mod Pathol; 2018 Jun; 31(6):910-922. PubMed ID: 29416107
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of CD68
Chohan MH; Perry M; Laurance-Young P; Salih VM; Foey AD
Br J Biomed Sci; 2023; 80():11065. PubMed ID: 37397243
[No Abstract] [Full Text] [Related]
4. Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer.
Jung M; Rose M; Knuechel R; Loeffler C; Muti H; Kather JN; Gaisa NT;
BMC Cancer; 2023 Feb; 23(1):113. PubMed ID: 36726072
[TBL] [Abstract][Full Text] [Related]
5. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
[TBL] [Abstract][Full Text] [Related]
6. Role Of Cd8+ Tumour-Infiltrating Lymphocytes In Predicting Regional Lymph Node Metastasis In Lip And Oral Cavity Squamous Cell Carcinoma.
Sukhera ZA; Zafar N; Ara N; Muneer S; Haroon A; Saeed Z
J Ayub Med Coll Abbottabad; 2023; 35(2):288-293. PubMed ID: 37422823
[TBL] [Abstract][Full Text] [Related]
7. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
[TBL] [Abstract][Full Text] [Related]
8. Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment.
Peng H; Wu X; Liu S; He M; Xie C; Zhong R; Liu J; Tang C; Li C; Xiong S; Zheng H; He J; Lu X; Liang W
Clin Transl Med; 2023 Jan; 13(1):e1155. PubMed ID: 36588094
[TBL] [Abstract][Full Text] [Related]
9. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018
[TBL] [Abstract][Full Text] [Related]
10. The preliminary exploration of immune microenvironment in oral leukoplakia concomitant with oral submucosal fibrosis: A comparative immunohistochemical study.
Cai X; Zhang J; Peng Y; Yao Z; Huang J; Tang Q; Bai J; Yan J; Li L; Zhang H; Li T
J Oral Pathol Med; 2023 Aug; 52(7):666-672. PubMed ID: 37084341
[TBL] [Abstract][Full Text] [Related]
11. Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment.
Hirai M; Kitahara H; Kobayashi Y; Kato K; Bou-Gharios G; Nakamura H; Kawashiri S
Int J Oncol; 2017 Jan; 50(1):41-48. PubMed ID: 27922697
[TBL] [Abstract][Full Text] [Related]
12. Extranodal extension in oral cancer: A role for the nodal microenvironment?
Pilborough AE; Lambert DW; Khurram SA
J Oral Pathol Med; 2019 Nov; 48(10):863-870. PubMed ID: 31087397
[TBL] [Abstract][Full Text] [Related]
13. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
[TBL] [Abstract][Full Text] [Related]
14. Association between spatial distribution of leukocyte subsets and clinical presentation of head and neck squamous cell carcinoma.
Netzer C; von Arps-Aubert V; Mačinković I; von der Grün J; Küffer S; Ströbel P; von Knethen A; Weigert A; Beutner D
Front Immunol; 2023; 14():1240394. PubMed ID: 38322012
[TBL] [Abstract][Full Text] [Related]
15. Role of tissue markers associated with tumor microenvironment in the progression and immune suppression of oral squamous cell carcinoma.
Ramalingam S; Shantha S; Muralitharan S; Sudhakar U; Thamizhchelvan H; Parvathi VD
Med Oncol; 2023 Sep; 40(10):303. PubMed ID: 37731058
[TBL] [Abstract][Full Text] [Related]
16. Plasma metabolomics of oral squamous cell carcinomas based on NMR and MS approaches provides biomarker identification and survival prediction.
Polachini GM; de Castro TB; Smarra LFS; Henrique T; de Paula CHD; Severino P; López RVM; Carvalho AL; de Mattos Zeri AC; Silva IDCG; Tajara EH
Sci Rep; 2023 May; 13(1):8588. PubMed ID: 37237049
[TBL] [Abstract][Full Text] [Related]
17. Epithelial PD-L1 expression at tumor front predicts overall survival in a cohort of oral squamous cell carcinomas from Sudan.
Gaafar NM; Osman TA; Elsheikh M; Ahmed IA; Dongre H; Fromreide S; Suleiman AM; Johannessen AC; Nginamau ES; Costea DE
Clin Exp Dent Res; 2022 Dec; 8(6):1467-1477. PubMed ID: 36177667
[TBL] [Abstract][Full Text] [Related]
18. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 Expression and Tumour Microenvironment Patterns in Resected Non-Small-Cell Lung Cancer.
Gurevičienė G; Matulionė J; Poškienė L; Miliauskas S; Žemaitis M
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541208
[No Abstract] [Full Text] [Related]
20. Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
William WN; Zhang J; Zhao X; Parra ER; Uraoka N; Lin HY; Peng SA; El-Naggar AK; Rodriguez-Canales J; Song J; Gillenwater AM; Wistuba II; Myers JN; Gold KA; Ferrarotto R; Hwu P; Davoli T; Lee JJ; Heymach JV; Papadimitrakopoulou VA; Lippman SM
Cancer; 2023 Mar; 129(5):714-727. PubMed ID: 36597662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
